Certolizumab pegol for maintenance of medically induced remission in Crohn's disease.
Okabayashi S, Yamazaki H, Yamamoto R, Anan K, Matsuoka K, Kobayashi T, Shinzaki S, Honzawa Y, Kataoka Y, Tsujimoto Y, Watanabe N.
Okabayashi S, et al. Among authors: anan k.
Cochrane Database Syst Rev. 2022 Jun 30;6(6):CD013747. doi: 10.1002/14651858.CD013747.pub2.
Cochrane Database Syst Rev. 2022.
PMID: 35771590
Free PMC article.
Review.